Research Overview: Metronidazole Pharmaceutical Analysis
Flagyl 200 mg is a pharmaceutical-grade metronidazole formulation manufactured by Abbott Healthcare Pvt. Ltd., representing a standardised nitroimidazole antimicrobial compound for laboratory investigation. This well-characterised pharmaceutical preparation enables researchers to study antimicrobial mechanisms, antiprotozoal activity, and anaerobic bacterial inhibition pathways in controlled experimental environments. The tablet formulation provides consistent dosing parameters essential for reproducible research protocols across comparative studies.
Research laboratories utilising Stroid UK Shop benefit from pharmaceutical-grade compounds that maintain strict manufacturing standards, enabling precise analytical work in antimicrobial research. The Abbott Healthcare manufacturing pedigree ensures batch-to-batch consistency critical for longitudinal studies examining metronidazole’s complex mechanism of action against anaerobic pathogens and parasitic organisms.
Laboratory Applications and Research Protocols
Metronidazole research encompasses multiple scientific disciplines, from microbiology studies investigating DNA damage mechanisms in anaerobic bacteria to pharmacokinetic analyses examining tissue penetration characteristics. The compound’s unique mechanism involves reduction to active metabolites that bind DNA and inhibit nucleic acid synthesis, making it valuable for researchers studying antimicrobial resistance patterns and cellular damage pathways.
Comparative efficacy studies utilise standardised Flagyl preparations to evaluate treatment protocols against specific pathogens including Giardia, Trichomonas, and Clostridium species. Researchers investigating metronidazole formulations can examine bioavailability differences between tablet matrices and establish dissolution profiles for pharmaceutical development research.
Advanced research applications include studying metronidazole’s anti-inflammatory properties independent of its antimicrobial activity, particularly in experimental models examining inflammatory bowel conditions. The compound’s interaction with cellular signalling pathways presents opportunities for researchers exploring novel therapeutic targets beyond traditional antimicrobial applications.
Pharmaceutical Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Metronidazole 200 mg |
| Manufacturer | Abbott Healthcare Pvt. Ltd. |
| CAS Number | 443-48-1 |
| Molecular Formula | C₆H₉N₃O₃ |
| Molecular Weight | 171.15 g/mol |
| Dosage Form | Oral tablet |
| Storage Conditions | Room temperature, protect from light |
| Pharmaceutical Grade | USP/BP compliant |
Laboratory researchers examining selective androgen receptor modulators alongside antimicrobial compounds can establish comprehensive study protocols, while those investigating peptide research may examine combination effects in cellular models. The pharmaceutical-grade quality ensures reliable analytical results across diverse research applications requiring consistent metronidazole concentrations.
Research Compliance and Laboratory Use
Flagyl 200 mg metronidazole tablets are supplied exclusively for in-vitro laboratory research and analytical studies. This pharmaceutical compound is not intended for human consumption or therapeutic application. Researchers must adhere to institutional safety protocols and maintain appropriate laboratory conditions when handling antimicrobial compounds for experimental purposes.
